# Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.

> PubMed lists PMID 1687076 in The Netherlands journal of medicine as Journal Article, Review, with publication-date metadata of 1991-12 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-1687076-octreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-1687076-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-1687076-octreotide-v1.json
- Content SHA-256: `d5bf2bddb042adc2a5338a15790b306a16c1cd559c6b756a788f7316ce5c8e5f`

## Claims and source pins

### Headline

Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders. ([`pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62`](#source-pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62))

### Summary

PubMed lists PMID 1687076 in The Netherlands journal of medicine as Journal Article, Review, with publication-date metadata of 1991-12 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62`](#source-pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62))

### Paragraph 1

PubMed lists PMID 1687076 in The Netherlands journal of medicine as Journal Article, Review, with publication-date metadata of 1991-12 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62`](#source-pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62`](#source-pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62))

## Sources

<a id="source-pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62"></a>
- **Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders. · retained source version 1:2013-11-21:current:4c9af057dc620930f4f4fe6bce7d8e318d0a9b83d96038363c40165822316198** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/1687076/) (`pubmed-observation-pmid-1687076-2013-11-21-4c9af057dc62`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-1687076-octreotide-v1.json SHA-256: d5bf2bddb042adc2a5338a15790b306a16c1cd559c6b756a788f7316ce5c8e5f.